help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dotzenrath, C.
Right arrow Articles by Larsson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dotzenrath, C.
Right arrow Articles by Larsson, C.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 3194-3196, Copyright © 1996 by Endocrine Society


ARTICLES

Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?

C Dotzenrath, BT Teh, F Farnebo, K Cupisti, A Svensson, A Toell, P Goretzki and C Larsson
Department of Surgery, Heinrich Heine Universitat, Dusseldorf, Germany.

Allelic loss of the retinoblastoma tumor suppressor gene has recently been shown to be highly specific for parathyroid carcinoma. It has been proposed that this genetic abnormality may have diagnostic and prognostic implications for parathyroid carcinoma, but to date no further studies are available to substantiate these findings. In the present study, three cases of atypical recurrent hyperparathyroidism were examined: a patient with parathyroid carcinoma and an autotransplanted adenoma that progressed into carcinoma, a patient with recurrent juvenile hyperparathyroidism, and a patient with severe recurrent secondary hyperparathyroid disease due to rapidly growing autotransplant. Six pairs each of sporadic parathyroid adenoma and secondary parathyroid disease were also studied for comparison. Allelic losses of RB and D13S71 at 13q14 was found in the parathyroid carcinoma and the corresponding autotransplant that had previously been considered benign tissue and in the case of recurrent juvenile hyperparathyroidism, but not in any of the other tumors. Our findings support the findings of the previous study that RB or 13q loss is specific for parathyroid tumors with increased aggressiveness and might be of clinical significance.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M.-H. Tan, C. Morrison, P. Wang, X. Yang, C. J. Haven, C. Zhang, P. Zhao, M. S. Tretiakova, E. Korpi-Hyovalti, J. R. Burgess, et al.
Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma
Clin. Cancer Res., October 1, 2004; 10(19): 6629 - 6637.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Sowa, H. Kaji, R. Kitazawa, S. Kitazawa, T. Tsukamoto, S. Yano, T. Tsukada, L. Canaff, G. N. Hendy, T. Sugimoto, et al.
Menin Inactivation Leads to Loss of Transforming Growth Factor {beta} Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion
Cancer Res., March 15, 2004; 64(6): 2222 - 2228.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. M. Shattuck, S. Valimaki, T. Obara, R. D. Gaz, O. H. Clark, D. Shoback, M. E. Wierman, K. Tojo, C. M. Robbins, J. D. Carpten, et al.
Somatic and Germ-Line Mutations of the HRPT2 Gene in Sporadic Parathyroid Carcinoma
N. Engl. J. Med., October 30, 2003; 349(18): 1722 - 1729.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
V M Howell, C J Haven, K Kahnoski, S K Khoo, D Petillo, J Chen, G J Fleuren, B G Robinson, L W Delbridge, J Philips, et al.
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
J. Med. Genet., September 1, 2003; 40(9): 657 - 663.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Hemmer, V.-M. Wasenius, C. Haglund, Y. Zhu, S. Knuutila, K. Franssila, and H. Joensuu
Deletion of 11q23 and Cyclin D1 Overexpression Are Frequent Aberrations in Parathyroid Adenomas
Am. J. Pathol., April 1, 2001; 158(4): 1355 - 1362.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Shane
Parathyroid Carcinoma
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 485 - 493.
[Full Text]


Home page
Am. J. Pathol.Home page
S. Kytola, F. Farnebo, T. Obara, J. Isola, L. Grimelius, L.-O. Farnebo, K. Sandelin, and C. Larsson
Patterns of Chromosomal Imbalances in Parathyroid Carcinomas
Am. J. Pathol., August 1, 2000; 157(2): 579 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sarquis, E. Friedman, W. L. Boson, R. S. Gomez, A. F. Dias, and L. De Marco
Microsatellite Instability in Sporadic Parathyroid Adenoma
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 250 - 252.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Carling, P. Correa, O. Hessman, J. Hedberg, B. Skogseid, D. Lindberg, J. Rastad, G. Westin, and G. Åkerström
Parathyroid MEN1 Gene Mutations in Relation to Clinical Characteristics of Nonfamilial Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2960 - 2963.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Palanisamy, Y. Imanishi, P. H. Rao, H. Tahara, R. S. K. Chaganti, and A. Arnold
Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1766 - 1770.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society